148 related articles for article (PubMed ID: 32248335)
1. The role of P2Y12 receptor inhibition in ischemic stroke on microglia, platelets and vascular smooth muscle cells.
Li F; Xu D; Hou K; Gou X; Li Y
J Thromb Thrombolysis; 2020 Nov; 50(4):874-885. PubMed ID: 32248335
[TBL] [Abstract][Full Text] [Related]
2. The role of P2Y
Gao Y; Yu C; Pi S; Mao L; Hu B
Cell Mol Life Sci; 2019 Jan; 76(2):341-354. PubMed ID: 30302530
[TBL] [Abstract][Full Text] [Related]
3. P2Y
Mansour A; Bachelot-Loza C; Nesseler N; Gaussem P; Gouin-Thibault I
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092903
[TBL] [Abstract][Full Text] [Related]
4. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
[TBL] [Abstract][Full Text] [Related]
5. Microglial P2Y12 deficiency/inhibition protects against brain ischemia.
Webster CM; Hokari M; McManus A; Tang XN; Ma H; Kacimi R; Yenari MA
PLoS One; 2013; 8(8):e70927. PubMed ID: 23940669
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
Schrottmaier WC; Kral JB; Badrnya S; Assinger A
Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory Effects of P2Y12 Receptor Antagonist on PAR1- and PAR4-AP-Induced Platelet Aggregation in Patients with Stroke or TIA.
Kamada A; Shimizu M; Oura K; Yoshida M; Tsuda K; Oi K; Ishigaku Y; Natori T; Narumi S; Itabashi R; Maeda T; Terayama Y
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105547. PubMed ID: 33360254
[TBL] [Abstract][Full Text] [Related]
8. Involvement of P2Y12 receptor in vascular smooth muscle inflammatory changes via MCP-1 upregulation and monocyte adhesion.
Satonaka H; Nagata D; Takahashi M; Kiyosue A; Myojo M; Fujita D; Ishimitsu T; Nagano T; Nagai R; Hirata Y
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H853-61. PubMed ID: 25681429
[TBL] [Abstract][Full Text] [Related]
9. P2Y
Hensch NR; Karim ZA; Pineda J; Mercado N; Alshbool FZ; Khasawneh FT
Biochem Biophys Res Commun; 2017 Nov; 493(2):1069-1074. PubMed ID: 28928091
[TBL] [Abstract][Full Text] [Related]
10. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y
Boncler M; Wzorek J; Wolska N; Polak D; Watala C; Rozalski M
Vascul Pharmacol; 2019 Feb; 113():47-56. PubMed ID: 30471364
[TBL] [Abstract][Full Text] [Related]
11. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y
Gündüz D; Tanislav C; Sedding D; Parahuleva M; Santoso S; Troidl C; Hamm CW; Aslam M
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146050
[TBL] [Abstract][Full Text] [Related]
12. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
[TBL] [Abstract][Full Text] [Related]
13. BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism.
Zhang S; Hu L; Du H; Guo Y; Zhang Y; Niu H; Jin J; Zhang J; Liu J; Zhang X; Kunapuli SP; Ding Z
Thromb Haemost; 2010 Oct; 104(4):845-57. PubMed ID: 20806121
[TBL] [Abstract][Full Text] [Related]
14. Structure, Pharmacology and Roles in Physiology of the P2Y
von Kügelgen I
Adv Exp Med Biol; 2017; 1051():123-138. PubMed ID: 28921447
[TBL] [Abstract][Full Text] [Related]
15. The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis.
Liu Z; Xiang Q; Mu G; Xie Q; Zhou S; Wang Z; Chen S; Hu K; Gong Y; Jiang J; Cui Y
Platelets; 2020; 31(1):3-14. PubMed ID: 30744477
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
[TBL] [Abstract][Full Text] [Related]
17. P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.
Liu F; Tantry US; Gurbel PA
Expert Opin Pharmacother; 2015 Jun; 16(8):1149-65. PubMed ID: 25873127
[TBL] [Abstract][Full Text] [Related]
18. G-protein-coupled receptors signaling pathways in new antiplatelet drug development.
Gurbel PA; Kuliopulos A; Tantry US
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316
[TBL] [Abstract][Full Text] [Related]
19. Platelet-related biomarkers and their response to inhibition with aspirin and p2y
Lowenstern A; Storey RF; Neely M; Sun JL; Angiolillo DJ; Cannon CP; Himmelmann A; Huber K; James SK; Katus HA; Morais J; Siegbahn A; Steg PG; Wallentin L; Becker RC;
J Thromb Thrombolysis; 2017 Aug; 44(2):145-153. PubMed ID: 28608165
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade: Are Two Better Than One?
Vaduganathan M; Bhatt DL
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):427-8. PubMed ID: 26912743
[No Abstract] [Full Text] [Related]
[Next] [New Search]
